通过巨细胞衍生的外体miRNA向癌症:对瘤进展和耐药性的影响
Prasanna Srinivasan Ramalingam1, Muhammad Afzal2, M Arockia Babu3
1Protein Engineering Lab, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Frontiers in immunology
|December 8, 2025
概括
携带microRNAs (miRNAs) 的巨细胞衍生外体对癌症治疗具有前景. 工程外体可以提供向的miRNA来克服药物和放射电阻,提供一种新的治疗方法.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物技术是生物技术.
背景情况:
- 巨细胞影响癌症的进展,转移和化学抵抗.
- 外体,一种细胞外囊泡,介导癌细胞和巨细胞之间的相互作用.
- 巨细胞衍生的外体在瘤微环境中起着重要作用.
研究的目的:
- 审查关于在瘤学中使用巨细胞衍生外体来进行microRNA (miRNA) 输送的文献.
- 评估这种方法的分子基础和治疗潜力,以增强癌症治疗.
- 突出外体miRNAs在克服癌症耐药性的诊断和治疗应用.
主要方法:
- 在癌症中对巨细胞衍生的外体和miRNA进行文献综合和当前研究的综述.
- 对基因调节的分子机制的评估 (转录后调节,蛋白质酸化).
- 分析工程外体的策略,以提供有针对性的miRNA.
主要成果:
- 巨细胞衍生的外体和它们的miRNAs有助于癌症的发展和进展.
- 工程外体可以提供特定的miRNA来调节瘤行为.
- 这些工程囊泡显示出在癌症治疗中克服药物和放射电阻的潜力.
结论:
- 来自巨细胞的外体是用于癌症治疗和诊断的多功能工具.
- 工程外体提供了针对性miRNA输送的新策略,以对抗癌症.
- 这种方法具有克服治疗耐药性和改善癌症治疗结果的巨大潜力.
相关概念视频
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


